EPW
HALO icon

Evolve Private Wealth’s Halozyme HALO Stock Holding History

Evolve Private Wealth’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Buy
+3,238
New +$221K 0.02% 817

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Evolve Private Wealth's HALO Position: Q2 2026 in Review

Evolve Private Wealth opened a new position in Halozyme (HALO) in Q2 2026: 3,238 shares worth $253K. The stake represents 0.02% of the portfolio and ranks #817 among its holdings.

668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Evolve Private Wealth held 3,238 shares of Halozyme worth $253K as of Q2 2026.
  • Halozyme was a new Evolve Private Wealth position in Q2 2026.
  • Halozyme made up 0.02% of Evolve Private Wealth's portfolio in Q2 2026, its #817 holding.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.